HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kata Bölcskei Selected Research

Peptide Hydrolases (Proteases)

2/2016Neutrophil elastase induces inflammation and pain in mouse knee joints via activation of proteinase-activated receptor-2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kata Bölcskei Research Topics

Disease

24Hyperalgesia
01/2022 - 05/2003
12Pain (Aches)
01/2022 - 09/2004
8Inflammation (Inflammations)
10/2021 - 02/2016
8Arthritis (Polyarthritis)
02/2021 - 07/2005
4Migraine Disorders (Migraine)
02/2022 - 01/2016
4Neuralgia (Stump Neuralgia)
03/2021 - 09/2003
4Rheumatoid Arthritis
02/2021 - 10/2014
4Demyelinating Diseases (Demyelinating Disease)
01/2020 - 12/2016
4Edema (Dropsy)
01/2019 - 10/2014
3Neuroinflammatory Diseases
02/2022 - 04/2020
2Hypotension (Low Blood Pressure)
01/2022 - 07/2005
2Facial Pain (Myofacial Pain)
04/2020 - 01/2016
2Chronic Pain
10/2017 - 01/2017
1Headache (Headaches)
10/2021
1Mitochondrial Diseases (Mitochondrial Disease)
10/2021
1Movement Disorders (Movement Disorder)
01/2019
1Mononeuropathies (Mononeuritis Multiplex)
01/2018
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
12/2017
1Necrosis
12/2017
1Infections
12/2017
1Mycoplasma Infections
12/2017
1Synovitis
02/2016
1Mood Disorders (Mood Disorder)
02/2016
1Hypersensitivity (Allergy)
01/2016
1Alzheimer Disease (Alzheimer's Disease)
04/2015
1Osteophyte
10/2014
1Hyperplasia
10/2014
1Immune System Diseases (Immune Disorders)
10/2014

Drug/Important Bio-Agent (IBA)

6resiniferatoxinIBA
02/2021 - 05/2003
6Capsaicin (Zostrix)FDA Link
02/2021 - 07/2005
6Formaldehyde (Formol)FDA Link
01/2018 - 09/2004
6TRPV1 receptorIBA
10/2017 - 07/2005
5AnkyrinsIBA
12/2019 - 01/2018
5Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
02/2016 - 09/2004
4Analgesics (Analgesic Drugs)IBA
01/2018 - 05/2003
3Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA
02/2022 - 01/2009
3NeuropeptidesIBA
02/2021 - 09/2003
3Freund's AdjuvantIBA
04/2020 - 07/2005
3CuprizoneIBA
12/2019 - 12/2016
3Peroxidase (Myeloperoxidase)IBA
01/2019 - 10/2014
3Opioid Analgesics (Opioids)IBA
01/2018 - 06/2007
3Morphine (MS Contin)FDA LinkGeneric
03/2009 - 05/2003
3Diclofenac (SR 38)FDA LinkGeneric
03/2009 - 05/2003
2Pharmaceutical PreparationsIBA
01/2022 - 01/2018
2CytokinesIBA
01/2022 - 10/2021
2incobotulinumtoxinAFDA Link
01/2019 - 01/2017
2Lipoxygenase (Lipoxygenase-1)IBA
02/2010 - 07/2005
2Non-Narcotic Analgesics (Analgesics, Non Narcotic)IBA
03/2009 - 06/2007
2CarrageenanIBA
01/2009 - 10/2005
2Streptozocin (Streptozotocin)FDA Link
10/2005 - 09/2004
1Neuroprotective AgentsIBA
02/2022
1Type II Vasoactive Intestinal Peptide ReceptorsIBA
02/2022
19-phenanthrolIBA
01/2022
1tofacitinibIBA
01/2022
1Etanercept (Enbrel)FDA Link
01/2022
1Janus Kinase InhibitorsIBA
01/2022
1Immunoglobulin G (IgG)IBA
01/2022
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022
1dimethyl trisulfideIBA
03/2021
1hemokinin-1IBA
04/2020
1IodidesIBA
01/2020
1Fluorescent Dyes (Fluorescent Probes)IBA
01/2020
1Sulfides (Thioethers)IBA
01/2019
1GYY 4137IBA
01/2019
1Type A Botulinum Toxins (Botox)FDA Link
01/2019
1Ion Channels (Ion Channel)IBA
01/2019
1Proteoglycans (Proteoglycan)IBA
12/2018
1Amine Oxidase (Copper-Containing)IBA
01/2018
1Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
01/2018
1Dipeptidyl-Peptidase IV InhibitorsIBA
01/2018
1VildagliptinIBA
01/2018
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2018
1AgglutininsIBA
12/2017
1Estradiol (Delestrogen)FDA LinkGeneric
10/2017
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2017
1Substance PIBA
01/2017
12,3,4-tri-O-acetylarabinopyranosyl isothiocyanate (AITC)IBA
06/2016
1Peptide Hydrolases (Proteases)FDA Link
02/2016
1U 0126 (UO 126)IBA
02/2016
1Leukocyte Elastase (Neutrophil Elastase)IBA
02/2016
1Sumatriptan (Imigran)FDA LinkGeneric
01/2016
1Nitroglycerin (Dynamite)FDA LinkGeneric
01/2016
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2016
1somatostatin receptor 2IBA
04/2015
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
04/2015
1Proteins (Proteins, Gene)FDA Link
04/2015
1AutoantibodiesIBA
03/2015
1Matrix Metalloproteinases (MMPs)IBA
03/2015
1gamma-Aminobutyric Acid (GABA)IBA
12/2012
1L 838,417IBA
12/2012
13'- (5- (1- hydroxy- 1- methylethyl)benzoimidazol- 1- yl)biphenyl- 2- carbonitrileIBA
12/2012
13- (4- t- butylphenyl)- N- (2,3- dihydrobenzo(b)(1,4)dioxin- 6- yl)acrylamideIBA
09/2010
1SB 705498IBA
09/2010
12,5-dichloro-4-bromophenol (B 2)IBA
02/2010

Therapy/Procedure

6Ligation
03/2021 - 09/2003
2Drug Therapy (Chemotherapy)
03/2021 - 01/2017
2Therapeutics
01/2019 - 10/2014
2Lasers (Laser)
12/2017 - 01/2016
1Aftercare (After-Treatment)
01/2022
1Injections
01/2018